LEADER 00000nam a2200421 i 4500 
001    978-981-10-7632-9 
003    DE-He213 
005    20180227075313.0 
006    m     o  d         
007    cr nn 008maaau 
008    180227s2018    si      s         0 eng d 
020    9789811076329|q(electronic bk.) 
020    9789811076312|q(paper) 
024 7  10.1007/978-981-10-7632-9|2doi 
040    GP|cGP|erda|dAS 
041 0  eng 
050  4 RC632.H65 
082 04 612.12|223 
100 1  Bhargava, Seema,|eauthor 
245 14 The clinical application of homocysteine /|cby Seema 
       Bhargava 
264  1 Singapore :|bSpringer Singapore :|bImprint: Springer,
       |c2018 
300    1 online resource (xix, 96 pages) :|billustrations, 
       digital ;|c24 cm 
336    text|btxt|2rdacontent 
337    computer|bc|2rdamedia 
338    online resource|bcr|2rdacarrier 
347    text file|bPDF|2rda 
505 0  Introduction -- Discovery and metabolism -- 
       Homocysteinemia and occlusive vascular disease -- 
       Homocysteinemia and hypertension -- Homocysteinemia and 
       its neurological effects -- Homocysteinemia in nephrology 
       practice -- Homocysteinemia and oncology -- 
       Homocysteinemia and otology -- Homocysteinemia and bones -
       - The body's inherent defence against homocysteinemia -- 
       Homocysteine and epigenetics -- Food fortification 
520    This book helps clinicians to optimally and appropriately 
       utilize homocysteine levels in the diagnosis, prediction 
       and management of and research into vascular disease and 
       many other conditions. It also familiarizes readers with 
       the pathophysiology and clinical implications of 
       hyperhomocysteinemia. Laboratory investigations are 
       gaining importance in the diagnosis and prognosis of 
       patients, and as such, scientists and laboratorians are 
       constantly attempting to identify new markers that will 
       help in earlier diagnosis and better prognostication of 
       conditions with high morbidity and mortality, as well as 
       high prevalence. According to the WHO, developing 
       countries are home to 80% of patients with coronary artery
       disease (CAD) and stroke - conditions with a mortality 
       second only to cancer. Intensive research in these areas 
       has resulted in the identification of homocysteine 
       (declared the 'marker of the millennium') and several new 
       markers for the diagnosis and prediction of CAD and 
       stroke. The book is a valuable resource for clinicians and
       consultants in practice, as well as for postgraduate and 
       undergraduate students of medicine, biotechnology and 
       biochemistry 
650  0 Homocysteine 
650 14 Medicine & Public Health 
650 24 Medical Biochemistry 
710 2  SpringerLink (Online service) 
773 0  |tSpringer eBooks 
856 40 |uhttp://dx.doi.org/10.1007/978-981-10-7632-9
       |zeBook(SpringerLink)